Can Molagri Scale the 'Evolutionary' Pesticide Gamble in Toronto?

In the world of deep tech, the most ambitious bets are often the ones that look the most precarious on paper. Molagri is exactly that kind of bet. As BetaKit first reported, the Toronto-based startup is attempting to engineer pesticides that evolve as quickly as the pests they target, swinging for the fences in a way that could genuinely put our city on the global map for high-science innovation—if they can survive the transition from YC hype to commercial reality.

BetaKit reports that the company was started by Min Jin and Zaky Hassan, two University of Toronto PhD candidates whose expertise lies in common cold coronaviruses. Their vision is to treat pesticide development like a flu vaccine: a backend process where the science evolves to meet the current strain so the end-user—the farmer—doesn't have to worry about which specific pest resistance is currently winning.

Technically, the company is leveraging AI-driven advancements in protein design. BetaKit reports that Molagri uses a non-infectious insect virus as a foundation, allowing them to engineer proteins that can "whitelist" and "blacklist" targets. This allows the team to tweak formulations rapidly to stay ahead of evolving pests.

***

**Priya's Take: The Risk Gap**

Here is where the story gets interesting for the local scene. Hassan told BetaKit that the duo initially sought funding from Canadian investors but were unsuccessful, a failure Hassan attributed to the risk aversion inherent in the Canadian investment landscape.

It is a frustratingly familiar narrative: Toronto produces world-class talent (Hassan notes the city is a "crazy place for talent" full of brilliant grad students and postdocs), but the local capital often lacks the stomach for the "high-risk, high-reward" nature of deep tech. While Canadian VCs hesitated, US-based deeptech VC Julian Capital and Y Combinator stepped in, providing $1 million USD (approximately $1.4 million CAD) in pre-seed capital.

That American capital is what allowed Molagri to secure lab space at the MaRS Discovery District and hire their first scientist. Now, as they prepare to pitch at Y Combinator’s Demo Day on Sept. 10, the goal is to build a "war chest" to hire more scientists and scale their operations back in Toronto.

***

Despite the Toronto roots, the immediate commercial focus is south of the border. BetaKit reports that Molagri’s initial "wedge product" targets tree fruits and tree nuts due to an "acute insecticide need," which directs much of their early attention toward California.

However, Hassan remains committed to the local ecosystem, telling BetaKit he is a "big proponent" of building bio companies in Canada to ensure a strong regional tech scene. Whether Molagri can successfully bridge the gap between a California-centric product market and a Toronto-based R&D hub remains to be seen, but it is exactly the kind of audacious science Toronto needs to champion.